Read UMR's July 13 Statement on NIH Funding in House Labor-HHS Appropriations Bill
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
NIH's Role In Sustaining the U.S. Economy | 2023 Update Now Available
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Where Is COVID Research Going Next?

NIAID divisional director Matthew Fenton, BU alum and former professor, talks about vaccine safety and what’s next for COVID research funding and the pandemic

Behind the scenes of the race to develop COVID vaccines in record time, Matthew Fenton and his colleagues at the National Institute of Allergy and Infectious Diseases (NIAID) worked around the clock to get more than $3 billion in emergency funds from the government funneled into clinical trials as soon as possible. It’s been an unprecedented year for Fenton’s team, and for his boss, Anthony Fauci, the NIAID director.